Restless legs syndrome due to interferon-α

Jeffrey S. LaRochelle, Barbara I. Karp*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


A patient developed restless legs symptoms paralleling the course of interferon-α (IFNα) therapy for chronic hepatitis C. Symptoms began during a course of IFNα, resolved with its suspension, and recurred on rechallenge. Restless legs syndrome may thus be an adverse effect of IFNα treatment.

Original languageEnglish
Pages (from-to)730-731
Number of pages2
JournalMovement Disorders
Issue number6
StatePublished - Jun 2004
Externally publishedYes


  • Interferon-α
  • Movement Disorder
  • Restless legs syndrome


Dive into the research topics of 'Restless legs syndrome due to interferon-α'. Together they form a unique fingerprint.

Cite this